Chemocentryx patents CCR6 antagonists

March 14, 2023

No Comments

Aryl sulfonyl compounds acting as C-C chemokine receptor type 6 (CCR6) antagonists have been...

BioWorld Science Dermatologic Patents

Today's news in brief

BioWorld

BioWorld briefs for Oct. 11, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for October 11, 2024.

Visualization of protein folding process

Protein design: if you can’t find ’em, make ’em

BioWorld

David Baker, director of the Institute for Protein Design at the University of Washington School of Medicine, is a pioneer in protein design. His contributions...

Prime’s $3.61B Bristol Myers deal is year’s fourth largest

BioWorld

In the year’s fourth-largest deal, Prime Medicine Inc. will collaborate with Bristol Myers Squibb Co. in a research collaboration and license agreement totaling...

Reverse engineering opens path for precisely targeted gene therapies for ALS and FTD

BioWorld Science

Researchers in the U.K. have succeeded in reverse engineering the defective cryptic splicing that drives amyotrophic lateral sclerosis (ALS) and frontotemporal...

Upgrade your daily dose of biopharma and medtech news

Chemocentryx patents CCR6 antagonists